CANDICE BAKER: Open Payments
NPI 1841288834 · CLINTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 18 payments from 8 companies in 2025. Trend: 2023 $146 · 2024 $296 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $79 |
| ABBVIE INC. | 4 | $75 |
| Astellas Pharma US Inc | 1 | $30 |
| PFIZER INC. | 1 | $24 |
| Exact Sciences Corporation | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: REXULTI, CAPLYTA, VRAYLAR, Veozah, PREVNAR 20, Cologuard Collection Kit, FANAPT, MOUNJARO.
Industry payments across MO — which companies pay providers there.
